← All indications
Nocturia
Frequent URINATION at night that interrupts sleep. It is often associated with outflow obstruction, DIABETES MELLITUS, or bladder inflammation (CYSTITIS).
Drugs by status
Approved for this indication (1)
Phase 4 trials (9)
Phase 3 trials (4)
Phase 2 trials (5)
Phase 1 trials (3)
Organizations
Organization Involved with Phase 4 Indications (13)
Organization Involved with Phase 3 Indications (10)
Organization Involved with Phase 2 Indications (23)
- Bay State Clinical Trials, Inc.
- Sanwa Kagaku Kenkyusho Co., Ltd.
- University of London
- Wellesley Pharmaceuticals
- Genova Clinical Research
- Rapid Medical Research, Inc.
- Avail Clinical Research
- Polytechnic University of Madrid
- Watson Pharmaceuticals
- Alabama Research Center, LLC
- Grove Hill Clinical Research
- Medical & Clinical Research Associates
- South Broward Research, LLC
- Accumed Research Associates
- Hudson Valley Urology, PC
- Urology Center of Florida
- Martin Diagnostic Clinic
- Tower Urology Medical Group
- Health Texas Research Institute
- Parkhurst Research Organization
- Urology Associates of North Texas
- Veeda Clinical Research
- SagaNatura
Organization Involved with Phase 1 Indications (4)
Organization Involved with Other Experimental Indications (7)